Author

Emre Aldinc

Alnylam Pharmaceuticals (United States)ORCID 0000-0002-7237-4760Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:GWAS / association mapping· 2 Assay:GWAS summary statistics· 2 Organism:human· 2 Approach:statistical model· 2

Frequent Co-Authors

David V. Erbe· 2 shared Gregory HinkleiD· 2 shared Margaret M. ParkeriD· 2 shared Paul NioiiD· 2 shared Simina TicauiD· 2 shared Aimée M. DeatoniD· 1 shared Akshay K. Vaishnaw· 1 shared Alexander O. Flynn-Carroll· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

David V. Erbe

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Association of the Transthyretin Variant V122I With Polyneuropathy Among Individuals of African Descent

Margaret M. Parker, Scott M. Damrauer, Catherine Tcheandjieu, David V. Erbe, Emre Aldinc, Philip Nigel Hawkins, Julian David Gillmore, Leland E. Hull, Julie Ann Lynch, Jacob Joseph, Simina Ticau, Alexander O. Flynn-Carroll, Aimée M. Deaton, Lucas D. Ward, Themistocles L. Assimes, , Paul Nioi

This study identifies a significant association between the V122I TTR variant and polyneuropathy in Black individuals, highlighting increased risk of hATTR amyloidosis manifestations.

Scientific Reports · Jun 2, 2021Peer-reviewedGenetic & Genomic Medicine

Transthyretin-stabilizing mutation T119M is not associated with protection against vascular disease or death in the UK Biobank

Margaret M. Parker, Simina Ticau, James Thomas Butler, David V. Erbe, Madeline P. Merkel, Emre Aldinc, Gregory Hinkle, Paul Nioi

The paper investigates the association between the TTR T119M mutation and vascular disease or death in the UK Biobank, finding no significant protective effect.

Amyloid · May 19, 2020Peer-reviewedGenetics